UBS Group »

Soleno Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Soleno Therapeutics

Jul 2023Oct 2023Jan 2024Apr 2024Jul 2024Oct 2024Jan 202500.5M1M1.5M2M020k40k
Value ($)Share countHistorical SLNO position of UBS Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.3M 50k 44.95
2024-09-30 $2.3M 45k 50.49
2024-06-30 $1.4M 34k 40.80
2024-03-31 $2.3M 54k 42.80
2023-12-31 $716k 18k 40.25
2023-06-30 $64 15 4.27